/C O R R E C T I O N -- Gesynta Pharma/

Contributed by: PR Newswire

Tags

Gesynta-Pharma

More Like This

Gynica announces First-in-Human Clinical Trial of Novel IntraVag© Treatment for Endometriosis

PR Newswire associated0

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation

Gedeon Richter: Medical Treatment of Endometriosis with a progressive approach

Business Wire logo

Vertex to Present New Data on JOURNAVX® That Demonstrates Effective Pain Management Following Aesthetic and Reconstructive Procedures

Lundbeck presents new real-world data highlighting meaningful improvements in patients severely impacted by migraine initiating Vyepti® (eptinezumab), at HCOP Annual Conference

Lundbeck showcases new clinical migraine data, including long-term preventive effectiveness of Vyepti® (eptinezumab) in patients severely impacted by migraine

Business Wire logo

Vertex Announces Key Advancements Across Kidney Portfolio

Figure 1: Mean NPRS Over Time in Phase 3 Study of Acute Pain Following Abdominoplasty (Graphic: Business Wire)

Vertex Announces Positive Results From the VX-548 Phase 3 Program for the Treatment of Moderate-to-Severe Acute Pain